Stroke patients with SLC6A4 hypermethylation might have reduced 5-HTT function and 5-HT availability, which would lead to decreased BDNF expression and thus suppress neurogenesis42,43 and promote inflammation44. This evidence concerns the gene BDNF and stroke disorder.